Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standardized toxicity tests

Wiebke Schmidt, Kathleen O'Rourke, Robert Hernan, Brian Quinn

Research output: Contribution to journalArticlepeer-review

90 Citations (Scopus)

Abstract

Human pharmaceuticals, like the lipid lowering agent gemfibrozil and the non-steroidal anti-inflammatory drug diclofenac are causing environmental concern. In this study, the marine mussel (Mytilus spp.) was exposed by injection to environmentally relevant and elevated (1 mu g/L and 1000 mu g/L) concentrations of both compounds and biomarker expression was observed. Gemfibrozil exposure induced biomarkers of stress (glutathione S-transferase and metallothionein) at both concentrations 24 h and 96 h after exposure, respectively. Biomarkers of damage (lipid peroxidation (LPO) and DNA damage) were significantly affected, as well as the biomarker for reproduction, alkali-labile phosphate assay, indicating the potential oxidative stress and endocrine disrupting effect of gemfibrozil. Diclofenac significantly induced LPO after 96 h indicating tissue damage. Additionally standard toxicity tests using the marine species Vibrio fischeri, Skeletonema costatum and Tisbe battagliai showed differences in sensitivity to both drugs in the mg/L range. Results indicate a suite of tests should be used to give accurate information for regulation.
Original languageEnglish
Pages (from-to)1389-1395
JournalMarine Pollution Bulletin
Volume62
Issue number7
DOIs
Publication statusPublished - Jul 2011
Externally publishedYes

Keywords

  • Gemfibrozil
  • Diclofenac
  • Mussel
  • Biomarker
  • Toxicity test
  • Ecotoxicology
  • Pollution
  • Pharmaceutical
  • Bioassay

Fingerprint

Dive into the research topics of 'Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standardized toxicity tests'. Together they form a unique fingerprint.

Cite this